Diagnostic Modalities for Parkinson's Disease

Clinical Diagnosis and Imaging

The American College of Radiology recommends I-123 ioflupane SPECT/CT brain imaging as the best diagnostic modality for Parkinson's disease, as it can differentiate Parkinsonian syndromes from essential tremor and drug-induced tremor early in the disease course 1
Clinical diagnosis is challenging, making imaging an essential diagnostic tool, with I-123 ioflupane SPECT/CT being the most valuable test for differentiating Parkinsonian syndromes from essential tremor and drug-induced tremor 1

I-123 ioflupane SPECT/CT brain imaging demonstrates abnormality early in disease course compared with anatomic imaging like CT or MRI, and a normal scan essentially excludes Parkinsonian syndromes 1
MRI brain is the optimal imaging modality for Parkinsonian syndromes due to soft-tissue characterization and sensitivity to iron deposition, with advanced MRI techniques offering earlier diagnostic opportunities 2
FDG-PET/CT brain is useful for discriminating PSP from idiopathic PD based on typical metabolic patterns, showing hypometabolism in medial frontal and anterior cingulated cortices, striatum, and midbrain 3
CT head is not the preferred imaging modality due to limited soft-tissue characterization compared to MRI, but can demonstrate patterns of regional volume loss characteristic of atypical Parkinsonism 3

The American College of Radiology suggests beginning with clinical assessment for cardinal features of PD, and when clinical diagnosis is uncertain, proceeding to imaging with I-123 ioflupane SPECT/CT (DaTscan) as the first-line imaging modality 1
Alternative imaging modalities include MRI brain without contrast, and FDG-PET/CT to differentiate PD from atypical Parkinsonism 2, 3

Early diagnosis is challenging as motor symptoms typically appear after approximately 40-50% of dopaminergic neurons in the substantia nigra have been lost, highlighting the importance of imaging in diagnosis 3
Emerging nuclear medicine tracers targeting postsynaptic dopamine receptors (D1 and D2) may play a larger role in future diagnostics, and a normal I-123 ioflupane SPECT/CT essentially excludes Parkinsonian syndromes 1